Anticancer Drug-Induced Capillary Leak Syndrome.
anticancer drugs
capillary leak syndrome
cytokines
gemcitabine
immunotherapy
monoclonal antibodies
Journal
Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
07
01
2022
revised:
12
02
2022
accepted:
14
02
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
The term capillary leak syndrome (CLS) describes the manifestations associated with an increased capillary permeability to proteins leading to an escape of plasma from the blood circulatory system to surrounding tissues, muscle, organs, or body cavities. This results clinically in the typical triad of hypotension, edema, and elevated hematocrit. The more severe cases of CLS may present with cardiovascular collapse, shock, and death. The most classic form of this pathology is represented by the idiopathic systemic CLS (SCLS) also called Clarkson's disease, but capillary leaks are also described as adverse drug reactions foremost among which are anticancer drugs. This review will focus on oncologic drugs such as gemcitabine, therapeutic growth factors or cytokines, and monoclonal antibodies (mAbs) that appear now as the strongest candidates for anticancer drug-induced CLS.
Identifiants
pubmed: 35570987
doi: 10.1016/j.ekir.2022.02.014
pii: S2468-0249(22)01194-9
pmc: PMC9091576
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
945-953Informations de copyright
© 2022 International Society of Nephrology. Published by Elsevier Inc.
Références
Bone Marrow Transplant. 2015 Apr;50(4):469-75
pubmed: 25581406
Bone Marrow Transplant. 2010 Sep;45(9):1417-22
pubmed: 20062097
Am J Kidney Dis. 2015 Jun;65(6):851-9
pubmed: 25480521
Am J Kidney Dis. 2020 Jul;76(1):63-71
pubmed: 31973908
Fundam Clin Pharmacol. 2004 Feb;18(1):85-91
pubmed: 14748759
Pharmacol Res. 2018 Oct;136:97-107
pubmed: 30170190
Am J Kidney Dis. 2021 Jun;77(6):990-992
pubmed: 33098925
Am J Med. 2009 Jun;122(6):e5-7
pubmed: 19486705
BMJ Case Rep. 2017 Aug 30;2017:
pubmed: 28855215
Support Care Cancer. 2019 Jul;27(7):2569-2577
pubmed: 30443809
N Engl J Med. 2006 Sep 7;355(10):1018-28
pubmed: 16908486
Blood. 2014 Jul 10;124(2):188-95
pubmed: 24876563
J Clin Invest. 1996 Dec 15;98(12):2819-26
pubmed: 8981930
Pathol Oncol Res. 2014 Apr;20(2):435-7
pubmed: 24163290
J Chemother. 2003 Jun;15(3):287-9
pubmed: 12868557
J Clin Cell Immunol. 2014;5:1000213
pubmed: 25405070
BMC Cancer. 2013 Nov 12;13:542
pubmed: 24215543
J Clin Med. 2019 Jan 26;8(2):
pubmed: 30691103
J Dermatol. 2020 Nov;47(11):1322-1325
pubmed: 32794214
Am J Kidney Dis. 2012 Apr;59(4):582-3; author reply 583
pubmed: 22444494
Clin Oncol (R Coll Radiol). 2006 Feb;18(1):90-1
pubmed: 16477934
N Engl J Med. 1985 Dec 5;313(23):1485-92
pubmed: 3903508
Cancer. 2011 Apr 1;117(7):1490-7
pubmed: 21425150
J Allergy Clin Immunol. 2017 Sep;140(3):663-670
pubmed: 28012935
Blood. 2008 Sep 1;112(5):1638-45
pubmed: 18565853
Kidney Int Rep. 2021 Feb 17;6(5):1416-1422
pubmed: 34013119
Mayo Clin Proc. 2010 Oct;85(10):905-12
pubmed: 20634497
Kidney Int. 2017 Jul;92(1):37-46
pubmed: 28318633
Chest. 1998 Dec;114(6):1779-81
pubmed: 9872221
Clin Oncol (R Coll Radiol). 2004 Dec;16(8):577-9
pubmed: 15630853
Immunotherapy. 2021 Jul;13(10):807-811
pubmed: 33969699
Crit Care Med. 2008 Jul;36(7):2184-7
pubmed: 18552679
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):609-618
pubmed: 28939140
J Pediatr Hematol Oncol. 2010 Mar;32(2):144-6
pubmed: 20057324
Intern Med. 2010;49(8):791-4
pubmed: 20424373
Crit Care Med. 2017 Jul;45(7):1216-1223
pubmed: 28622216
Front Immunol. 2021 Oct 12;12:745320
pubmed: 34712233
Gastroenterol Clin Biol. 2007 Dec;31(12):1143-5
pubmed: 18176375
CEN Case Rep. 2018 May;7(1):110-113
pubmed: 29344912
Mol Ther Oncolytics. 2016 Apr 20;3:16011
pubmed: 27626062
Curr Opin Nephrol Hypertens. 2019 Mar;28(2):113-119
pubmed: 30585851
Blood. 1999 Oct 1;94(7):2217-24
pubmed: 10498591
Br J Haematol. 2010 Nov;151(3):209-20
pubmed: 20735400
J Clin Med. 2018 Nov 06;7(11):
pubmed: 30404164
J Dig Dis. 2012 Jan;13(1):60-4
pubmed: 22188918
Blood. 2010 Apr 1;115(13):2723-4
pubmed: 20360479
Chest. 1993 Jul;104(1):123-6
pubmed: 8325053
Ann Oncol. 2008 Jan;19(1):191-2
pubmed: 18084047
J Cancer Res Ther. 2015 Jul-Sep;11(3):653
pubmed: 26458636
Biol Blood Marrow Transplant. 2020 Jun;26(6):1071-1076
pubmed: 32088364
Nat Rev Clin Oncol. 2018 Jan;15(1):47-62
pubmed: 28925994
Semin Arthritis Rheum. 2017 Feb;46(4):509-512
pubmed: 27637319
Blood. 2003 Oct 1;102(7):2379-86
pubmed: 12791647
Ann Oncol. 2001 Nov;12(11):1651-2
pubmed: 11822767
Semin Oncol. 1996 Oct;23(5 Suppl 10):3-15
pubmed: 8893876
Asian Pac J Cancer Prev. 2015;16(10):4369-76
pubmed: 26028101
Ann Pharmacother. 2016 May;50(5):416-22
pubmed: 26917818
Am J Med. 2017 Oct;130(10):1219.e19-1219.e27
pubmed: 28602874
J Oncol Pharm Pract. 2016 Oct;22(5):725-8
pubmed: 26071595
Am J Clin Oncol. 2002 Feb;25(1):96-100
pubmed: 11823707
J Thorac Oncol. 2019 Jun;14(6):e131-e132
pubmed: 31122567
Biochimie. 2014 Aug;103:71-9
pubmed: 24732633
Mayo Clin Proc Innov Qual Outcomes. 2021 Jun 07;5(3):670-674
pubmed: 34195558
J Allergy Clin Immunol. 2019 Jan;143(1):433-436
pubmed: 30244023
Ann Intern Med. 2011 Apr 5;154(7):464-71
pubmed: 21464348
Cancer. 1997 Jul 15;80(2):286-91
pubmed: 9217042
JAMA. 2013 Feb 20;309(7):678-88
pubmed: 23423413
J Med Case Rep. 2016 May 24;10:125
pubmed: 27386947
Ann Intern Med. 2010 Jul 20;153(2):90-8
pubmed: 20643990
Blood. 2012 May 3;119(18):4321-32
pubmed: 22411873
J Allergy Clin Immunol. 2009 Nov;124(5):1111-3
pubmed: 19703708
Ann Pharmacother. 2010 Mar;44(3):587-9
pubmed: 20150504